Genmab AS - Company Profile
Powered by
All the data and insights you need on Genmab AS in one report.
- Save hours of research time and resources with
our up-to-date Genmab AS Strategy Report
- Understand Genmab AS position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Genmab AS (Genmab) focuses on the research and development of antibody therapies for the treatment of cancer. Focus on research and development activities, proprietary technology platforms, and improved operational performance are its major strengths, even as geographic concentration is a cause for concern to the company. Collaboration with BioNTech SE, strong product pipeline and focus on cancer provides growth opportunities to the company. However, tightening of the FDA’s regulatory oversight, uncertain R&D outcomes, and competitive pressure could affect the company’s business operations.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer